What Radius Health, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Von Eschenbach Andrew C. | Director | Aug 15 | Disposition to Issuer · D | −5,500 | $10.00 | −$55K | 0 |
| Dere Willard H | Director | Aug 15 | Disposition to Issuer · D | −1,895 | $10.00 | −$19K | 0 |
| Dere Willard H | Director | Aug 15 | Tender Offer · U | −21,300 | $10.00 | −$213K | 1,895 |
| Sanders Machelle | Director | Aug 15 | Disposition to Issuer · D | −5,500 | $10.00 | −$55K | 0 |
| Hughes Owen | Director | Aug 15 | Tender Offer · U | −21,650 | $10.00 | −$217K | 0 |
| Murphy Sean | Director | Aug 15 | Tender Offer · U | −5,500 | $10.00 | −$55K | 0 |
| Garnier Jean Pierre | Director | Aug 15 | Disposition to Issuer · D | −5,500 | $10.00 | −$55K | 0 |
| Garnier Jean Pierre | Director | Aug 15 | Tender Offer · U | −26,800 | $10.00 | −$268K | 5,500 |
| Martin G. Kelly | CEO and President | Aug 15 | Disposition to Issuer · D | −75,000 | $10.00 | −$750K | 0 |
| Messersmith Elizabeth | Senior Vice President | Aug 15 | Disposition to Issuer · D | −70,000 | $10.00 | −$700K | 0 |
| Holtschlag Danielle | Vice President, Sales | Aug 15 | Disposition to Issuer · D | −25,000 | $10.00 | −$250K | 0 |
| Friedman Cathy | Director | Aug 15 | Disposition to Issuer · D | −26,800 | $10.00 | −$268K | 0 |
| Shah Chhaya | Chief Business Officer | Aug 15 | Disposition to Issuer · D | −94,645 | $10.00 | −$946K | 0 |
| Rubric Capital Management Lp | 10% owner | Aug 11 | Open-market buy · P | +1,678,954 | $10.07 | +$16.9M | 8,642,271 |
| Biotech Target N V | 10% owner | Aug 11 | Tender Offer · U | −8,733,538 | $10.00 | −$87.3M | 0 |
| Rubric Capital Management Lp | 10% owner | Aug 10 | Open-market buy · P | +4,012 | $10.07 | +$40.4K | 6,963,317 |
| Biotech Target N V | 10% owner | May 18 | Open-market buy · P | +477,824 | $5.57 | +$2.66M | 8,733,538 |
| Conley Mark William | VP, Chief Financial Officer | Mar 15 | Grant / award · A | +50,000 | — | — | 50,000 |
| Martin G. Kelly | CEO and President | Feb 21 | Grant / award · A | +960,000 | — | — | 960,000 |
| Martin G. Kelly | CEO and President | Feb 21 | Grant / award · A | +75,000 | — | — | 75,000 |
Loading...
